Cargando…
Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression
BACKGROUND: Up to 60% of pediatric renal transplant recipients with end-stage renal disease due to primary focal and segmental glomerulosclerosis (FSGS) may develop recurrent disease. Such recurrence is associated with poor prognosis if no remission is achieved. We report a single center experience...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981666/ https://www.ncbi.nlm.nih.gov/pubmed/35382760 http://dx.doi.org/10.1186/s12882-022-02768-w |